|
|
|
|
|
RRT management in precision medicinetime |
Li Jia-yu, Yu Kai-jiang |
Department of Intensive Care Unit, the Cancer Hospital of Harbin Medical University, Harbin 150081, China |
|
|
Abstract Renal replacement therapy (RRT) is the main treatment for critically ill patients with acute kidney injury (AKI). The timely and reasonable use of RRT can alleviate the patient′s condition. Although the RRT has been used since the last century, many aspects of this treatment have not yet been agreed. Moreover, there is also some considerable variability in clinical practice, resulting in high rates of mortality in critically ill patients such as AKI. In 2016, the 17th Acute Disease Quality Initiative International Consensus Conference (ADQI) proposed to implement “precision RRT” for patients through specific information such as patient selection, timing of treatment, solute control, and fluid management.
|
Received: 11 December 2017
|
Corresponding Authors:
Yu Kai-jiang, E-mail:drkaijiang@sohu.com
|
|
|
|
[1]Scribner BH, Caner JE, Buri R. The technique of continuous hemodialysis[J].Trans Am Soc Artif Intern Organs, 1960, 6:88-103.
[2]Kellum JA, Mehta RL, Angus DC, et al. The first international consensus conference on continuous renal replacement therapy[J]. Kidney Int, 2002, 62(5):1855-1863.
[3]Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: Introducing Precision Renal Replacement Therapy[J]. Blood Purif, 2016, 42(3):221-223.
[4]Cerdá J, Baldwin I, Honore PM, et al.Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy[J]. Blood Purif, 2016, 42(3):248-265.
[5]Kumar VA, Craig M, Depner TA, et al. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit[J]. Am J Kidney Dis, 2000, 36(2): 294-300.
[6]Ostermann M, Joannidis M, Pani A, et al. Patient Selection and Timing of Continuous Renal Replacement Therapy[J]. Blood Purif, 2016, 42(3):224-237.
[7]Wu VC, Wang CH, Wang WJ, et al. Sustained low-efficiency dialysis versus continuous veno-venous hemofiltrationfor postsurgical acute renal failure[J]. Am J Surg, 2010, 199(4):466-476.
[8]Khanal N, Marshall MR, Ma TM, et al. Comparison of outcomes by modality for critically ill patients requiring renal replacement therapy: a single-centre cohort study adjusting for time-varying illness severity and modality exposure[J]. Anaesth Intensive Care, 2012, 40(2):260-268.
[9]Kumar N, Ahlawat RS. Extended daily dialysis in acute renal failure: a new therapeutic approach[J]. Iran J Kidney Dis, 2007, 1(2):63-72.
[10]Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis[J]. Am J Kidney Dis, 2015, 66(2):322- 330.
[11]Schwenger V, Weigand MA, Hoffmann O, et al. Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury-a randomized interventional trial: the renal replacement therapy study in intensive care unit patients[J]. Crit Care, 2012, 16(4):R140.
[12]Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis[J]. Crit Care, 2011, 15(1):R72.
[13]Wierstra BT, Kadri S, Alomar S, et al. The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis[J]. Crit Care, 2016, 20(1):122.
[14]Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: a systematic review[J]. JAMA, 2008, 299(7):793-805.
[15]Seabra VF, Balk EM, Liangos O, et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis[J]. Am J Kidney Dis, 2008, 52(2):272-284.
[16]Macedo E, Mehta RL. Continuous dialysis therapies: core curriculum 2016[J]. Am J Kidney Dis, 2016, 68(4):645-657.
[17]Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012, 2:1-138.
[18]Bagshaw SM, Lamontagne F, Joannidis M, et al. When to start renal replacement therapy in critically ill patients with acute kidney injury: comment on AKIKI and ELAIN[J]. Crit Care, 2016, 20(1):245.
[19]Clark WR, Letteri JJ, Uchino S, et al. Recent clinical advances in the management of critically ill patients with acute renal failure[J]. Blood Purif, 2006, 24(5-6):487-498.
[20]Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study[J]. Crit Care Med, 2009, 37(9):2576-2582.
[21]Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision Continuous Renal Replacement Therapy and Solute Control[J]. Blood Purif, 2016, 42(3):238-247.
[22]Lewis SJ, Mueller BA. Antibiotic dosing in patients with acute kidney injury: “enough but not too much” [J]. J Intensive Care Med, 2016, 31(3): 164-176.
[23]Yasuda H, Uchino S, Uji M, et al. The lower limit of intensity to control uremia during continuous renal replacement therapy[J]. Crit Care, 2014, 18(5):539.
[24]Naka T, Bellomo R, Morimatsu H, et al. Acid-base balance in combined severe hepatic and renal failure: a quantitative analysis[J]. Int J Artif Organs, 2008, 31(4):288-294.
[25]Murugan R, Hoste E, Mehta RL, et al. Precision Fluid Management in Continuous Renal Replacement Therapy[J]. Blood Purif, 2016, 42(3):266-278.
[26]Dangoisse C, Dickie H, Tovey L, et al. Correction of hyper- and hyponatraemia during continuous renal replacement therapy[J]. Nephron Clin Pract, 2014, 128(3-4):394-398.
[27]Gibney N, Cerda J, Davenport A, et al. Volume management by renal replacement therapy in acute kidney injury[J]. Int J Artif Organs, 2008, 31(2):145-155. |
|
|
|